Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Conversation logo

The Indonesian government policy to exclude the elderly (aged 60 years and above) in the first phase of the free COVID-19 vaccination program could hinder the vaccine’s impact in lowering mortality rates.

As of 13 January 2021, the government prioritises early-stage vaccination for health workers, civil servants, and citizens aged 18-59 years old. The CoronaVac vaccines from Chinese company Sinovac will not be used to vaccinate elderly citizens aged 60 years old and above.

Considering the enormous COVID-19 mortality rates in Indonesia, the highest in Southeast Asia, which are dominated by those in the 60 years and above age bracket (45% of the total confirmed deaths from COVID-19), this policy is problematic.

In addition, this policy is inconsistent with the technical guide regarding vaccine recipient prioritisation issued by the government on 4 January 2021. This guide also incorporates the technical recommendation from the World Health Organization (WHO) to prioritise health workers in the first phase of vaccination, and then civil servants and those aged 60 and above in the second phase (estimated to be January-April 2021).

Read the full article on The Conversation website, co-written by Kartika Saraswati (Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine).

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Misophonia: nearly one in five UK adults have the condition causing extreme reactions to certain sounds

Many of us have sounds that we find to be annoying. But for some people, certain sounds actually trigger extreme reactions.

Any type of hormonal contraceptive may increase risk of breast cancer

An analysis of data by researchers at the Nuffield Department of Population Health’s Cancer Epidemiology Unit has shown that use of progestogen-only hormonal contraceptives is associated with a 20-30% higher risk of breast cancer. The results are published in PLOS Medicine.

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.